Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

One approach to improving efficacy in MS therapy is to identify medications that provide additive or synergistic benefit in combination. Orally administered cholesterol-lowering HMG-CoA reductase inhibitors (known as statins), which exhibit immunomodulatory properties and are effective in treatment...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Stüve, Olaf, Youssef, Sawsan, Weber, Martin S., Nessler, Stefan, von Büdingen, Hans-Christian, Hemmer, Bernhard, Prod’homme, Thomas, Sobel, Raymond A., Steinman, Lawrence, Zamvil, Scott S.
Format: Članak
Jezik:English
Izdano: American Society for Clinical Investigation 2006
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1401481/
https://ncbi.nlm.nih.gov/pubmed/16543951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI25805
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC1401481/
https://ncbi.nlm.nih.gov/pubmed/16543951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI25805

Similar Items